IRWD

Peers: ABBV VRTX ALNY GILD INCY NBIX REGN BIIB BMY EXEL

| Held by: VTI IWM FNDA VXF IWO IBB XBI VTWO SCHA FESM

Index	RUT	P/E	21.76	EPS (ttm)	0.15	Insider Own	3.61%	Shs Outstand	162.68M	Perf Week	-29.71%
Market Cap	546.60M	Forward P/E	2.87	EPS next Y	1.17	Insider Trans	-5.77%	Shs Float	156.80M	Perf Month	-35.14%
Enterprise Value	1.00B	PEG	0.03	EPS next Q	0.19	Inst Own	95.46%	Short Float	6.04%	Perf Quarter	6.33%
Income	29.48M	P/S	1.61	EPS this Y	482.22%	Inst Trans	0.94%	Short Ratio	2.26	Perf Half Y	164.57%
Sales	338.99M	P/B	-	EPS next Y	33.97%	ROA	7.51%	Short Interest	9.46M	Perf YTD	-0.30%
Book/sh	-1.62	P/C	3.89	EPS next 5Y	110.04%	ROE	-	52W High	5.78 -41.87%	Perf Year	93.66%
Cash/sh	0.86	P/FCF	8.08	EPS past 3/5Y	-88.04% -47.49%	ROIC	22.45%	52W Low	0.53 537.45%	Perf 3Y	-70.58%
Dividend Est.	-	EV/EBITDA	6.81	Sales past 3/5Y	-5.30% -3.89%	Gross Margin	99.44%	Volatility	12.53% 8.56%	Perf 5Y	-62.83%
Dividend TTM	-	EV/Sales	2.96	EPS Y/Y TTM	1236.48%	Oper. Margin	42.92%	ATR (14)	0.40	Perf 10Y	-56.37%
Dividend Ex-Date	-	Quick Ratio	1.13	Sales Y/Y TTM	-10.42%	Profit Margin	8.70%	RSI (14)	31.22	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	1.13	EPS Q/Q	906.14%	SMA20	-25.15%	Beta	0.23	Target Price	8.43
Payout	0.00%	Debt/Eq	-	Sales Q/Q	33.26%	SMA50	-20.69%	Rel Volume	2.76	Prev Close	3.79
Employees	253	LT Debt/Eq	-	Earnings	Feb 25 BMO	SMA200	58.53%	Avg Volume	4.19M	Price	3.36
IPO	Feb 03, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	84.62% -6.30%	Trades		Volume	11,562,674	Change	-11.35%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-05-26	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform	$8
Apr-15-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-15-25	Downgrade	Jefferies	Buy → Hold
Apr-14-25	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
Sep-09-24	Initiated	Leerink Partners	Market Perform	$5
Aug-08-24	Downgrade	CapitalOne	Overweight → Equal Weight	$12 → $4
Jan-17-24	Initiated	Craig Hallum	Buy	$21
Dec-14-23	Initiated	Wells Fargo	Overweight	$20
Nov-09-23	Initiated	Jefferies	Buy	$21
Sep-28-23	Initiated	JMP Securities	Mkt Outperform	$22
Sep-02-22	Initiated	CapitalOne	Overweight	$15
Apr-22-22	Initiated	Piper Sandler	Overweight	$16
Sep-30-20	Downgrade	Wells Fargo	Overweight → Equal Weight	$14 → $9
Jun-17-20	Initiated	Northland Capital	Outperform	$14
Jul-10-19	Resumed	Credit Suisse	Neutral
Mar-27-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Feb-25-19	Upgrade	H.C. Wainwright	Sell → Neutral	$14
Jan-24-19	Upgrade	JP Morgan	Underweight → Neutral
Nov-07-18	Downgrade	JP Morgan	Neutral → Underweight
Nov-07-18	Downgrade	Credit Suisse	Outperform → Neutral

Show Previous Ratings

Today 04:03PM	Ironwood Pharmaceuticals Inc (IRWD) Q4 2025 Earnings Call Highlights: Strong LINZESS Sales and ... (GuruFocus.com) -11.35%
03:29PM	Ironwood Pharmaceuticals Q4 Earnings Call Highlights (MarketBeat)
12:35PM	Ironwood Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary (Moby)
12:15PM	Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
07:28AM	Ironwood: Q4 Earnings Snapshot (Associated Press Finance)
07:05AM	Loading…
07:05AM	Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook (Business Wire)
Feb-23-26 09:07AM	What's in Store for These 5 Medical Companies This Earnings Season? (Zacks) -5.30%
Feb-20-26 10:57AM	Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now? (Zacks) -14.10%
Feb-18-26 04:21PM	Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call (Business Wire)
Feb-13-26 01:11PM	Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y (Zacks)
Feb-12-26 10:35AM	IRWD Rises 307% in 6 Months: Is This an Indication to Buy the Stock? (Zacks)
Feb-08-26 08:28AM	3 Stocks Trading Near $5 With Massive Earnings Upside (MarketBeat)
Feb-05-26 08:48AM	Does Ironwood's Bullish 2026 View Signal Greater Linzess Adoption? (Zacks)
Feb-04-26 09:06AM	Craig-Hallum Bullish on Ironwood Pharmaceuticals (IRWD), Keeps Buy Rating (Insider Monkey) -6.37%
Jan-26-26 02:11AM	Zacks.com featured highlights include IPG Photonics, Ironwood and Science Applications (Zacks)
10:33AM	Loading…
Jan-23-26 10:33AM	4 Stocks Trading Near 52-Week High With More Upside Potential (Zacks)
Jan-08-26 09:36AM	Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics (Zacks)
Jan-07-26 03:25PM	Ironwood Pharmaceuticals' 2026 Guidance Shock Sparks a Major Re-Rating (MarketBeat) -5.12%
08:45AM	5 Small Drug Stocks to Buy as Industry Recovery Picks Up (Zacks)
Jan-05-26 10:28AM	Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026 (Zacks) +7.49%
Jan-03-26 07:20AM	Ironwood backs FY25 revenue view $290M-$310M, consensus $306.97M (TipRanks)
07:20AM	Ironwood sees FY26 revenue $450M-$475M, consensus $319.47M (TipRanks)
Jan-02-26 12:21PM	Ironwood Pharmaceuticals Stock Soars as Drug-Price Cut Boosts Prospects for 2026 (Barrons.com) +26.71%
07:05AM	Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance (Business Wire)
Dec-10-25 11:30AM	Why Is Ironwood (IRWD) Up 24.9% Since Last Earnings Report? (Zacks)
Nov-28-25 10:11AM	Ironwood (IRWD) Skyrockets 23% as Govt Price for Linzess Falls Within Expectations (Insider Monkey) -9.33%
Nov-27-25 11:58AM	IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick? (Zacks)
Nov-21-25 10:30AM	Can Linzess Continue to Aid IRWD's Top Line After a Strong Q3? (Zacks)
Nov-13-25 10:36AM	IRWD Rises 110% in a Month: Should You Buy, Sell or Hold the Stock? (Zacks) +8.36%
Nov-11-25 09:56AM	IRWD Beats on Q3 Earnings & Revenues, Raises 2025 View, Stock Soars (Zacks) +14.23%
08:25AM	Loading…
Nov-10-25 08:25AM	Ironwood Pharmaceuticals (IRWD) Q3 Earnings and Revenues Surpass Estimates (Zacks) +31.77%
07:21AM	Ironwood: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance (Business Wire)
Nov-06-25 07:35AM	Former blockbuster Linzess grows label with paediatric IBS-C approval (Pharmaceutical Technology)
Nov-05-25 05:35PM	Xencor (XNCR) Reports Q3 Loss, Misses Revenue Estimates (Zacks) +10.16%
Oct-20-25 09:15AM	Xeris Biopharma Holdings, Inc. (XERS) Hit a 52 Week High, Can the Run Continue? (Zacks) +7.69%
Oct-16-25 07:56AM	BioCryst (BCRX) Soars 6.1%: Is Further Upside Left in the Stock? (Zacks)
Oct-15-25 09:17AM	Teladoc Health Expands Clarity Platform With Workplace Safety Tool (Zacks) +8.78%
06:19AM	Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics (Zacks)
Oct-14-25 10:57AM	5 Small Drug Stocks to Buy as the Industry Shows Some Recovery (Zacks)
09:50AM	Why Ironwood Pharmaceuticals (IRWD) is a Top Momentum Stock for the Long-Term (Zacks)
Sep-22-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Aug-21-25 09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks) +7.27%
Aug-08-25 10:36AM	IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates (Zacks)
Aug-07-25 08:25AM	Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates (Zacks) +9.32%
07:26AM	Ironwood: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance (Business Wire)
Jun-06-25 11:31AM	Why Is Ironwood (IRWD) Down 18.4% Since Last Earnings Report? (Zacks) +6.58%
May-08-25 09:55AM	IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates (Zacks) -11.63%
May-07-25 08:20AM	Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -14.55%
07:26AM	Ironwood: Q1 Earnings Snapshot (Associated Press Finance)
07:05AM	Ironwood Pharmaceuticals Reports First Quarter 2025 Results (Business Wire)
May-06-25 10:00AM	Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
May-05-25 07:15AM	Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-03-25 10:24PM	The 1-Minute Market Report May 4, 2025 (Seeking Alpha)
May-01-25 10:01AM	Analysts Estimate Ironwood Pharmaceuticals (IRWD) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-30-25 04:25PM	Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference (Business Wire)
Apr-28-25 10:25AM	The 1-Minute Market Report April 27, 2025 (Seeking Alpha) +9.23%
Apr-25-25 07:05AM	Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance (Business Wire)
Apr-22-25 04:05PM	Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support (Business Wire) +7.66%
Apr-16-25 01:07PM	Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News (Zacks)
Apr-15-25 09:18AM	Ironwood Shares Tank on Regulatory Update for Apraglutide (Zacks) +11.47%
07:12AM	Ironwoods shares sink as FDA demands new trial for lead drug (Pharmaceutical Technology)
Apr-14-25 07:00AM	Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide (Business Wire) -31.48%
Apr-13-25 10:44AM	The 1-Minute Market Report April 13, 2025 (Seeking Alpha)
Apr-10-25 10:49AM	Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth (Seeking Alpha)
09:25AM	Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday? (Insider Monkey)
Apr-01-25 10:28AM	Corcept (CORT) Stock Jumps 109.1%: Will It Continue to Soar? (Zacks)
Mar-31-25 08:05AM	The 1-Minute Market Report March 30, 2025 (Seeking Alpha)
Mar-27-25 04:05PM	Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing (Business Wire)
Mar-25-25 11:08AM	Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains? (Zacks)
Mar-02-25 12:24PM	Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stock to Buy Now? (Insider Monkey)
Feb-28-25 02:14AM	Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Call Highlights: Strong Prescription ... (GuruFocus.com)
Feb-27-25 11:20PM	Q4 2024 Ironwood Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -5.26%
08:15AM	Ironwood Pharmaceuticals (IRWD) Q4 Earnings and Revenues Miss Estimates (Zacks)
07:20AM	Ironwood: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance (Business Wire)
Feb-26-25 08:13AM	Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-20-25 04:00PM	Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call (Business Wire)
Feb-05-25 06:28PM	Millrose Properties Set to Join S&P SmallCap 600 (PR Newswire) -8.06%
Jan-29-25 04:05PM	Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future (Business Wire) -38.17%
Jan-18-25 08:20AM	Ozempic, Xtandi among next 15 drugs selected for U.S. price talks (TipRanks)
Dec-20-24 09:15AM	Heres Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD) (Insider Monkey) +14.69%
Nov-26-24 04:01PM	Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference (Business Wire) +5.07%
Nov-13-24 04:01PM	Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference (Business Wire)
Nov-08-24 04:01AM	Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... (GuruFocus.com) +6.44%
Nov-07-24 08:15AM	Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates (Zacks) -7.54%
07:20AM	Ironwood: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Ironwood Pharmaceuticals Reports Third Quarter 2024 Results (Business Wire)
Nov-06-24 07:29AM	Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com) +12.25%
Oct-28-24 07:00AM	Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024 (Business Wire)
Oct-24-24 04:00PM	Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call (Business Wire)
Oct-16-24 01:06PM	State Street Corp's Strategic Acquisition of Ironwood Pharmaceuticals Shares (GuruFocus.com)
08:58AM	Is Ironwood Pharmaceuticals, Inc. (IRWD) the Penny Stock with the Biggest Upside Potential According to Analysts? (Insider Monkey)
Oct-09-24 05:36PM	Ironwood Pharmaceuticals Inc (IRWD) Q2 2024 Earnings Call Highlights: Strong LINZESS Demand ... (GuruFocus.com)
Sep-17-24 08:40AM	Implied Volatility Surging for Ironwood (IRWD) Stock Options (Zacks)
Sep-01-24 10:26PM	Ironwood Pharmaceuticals, Inc. (IRWD): The Best Multibagger Penny Stock of 2025? (Insider Monkey)
Aug-29-24 08:41PM	10 Best Multibagger Penny Stocks of 2025 (Insider Monkey) +7.58%
04:01PM	Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference (Business Wire)
Aug-09-24 10:56AM	Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates (Zacks)

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
John Minardo	Chief Legal Officer	Feb 24 '26	Sale	3.66	19,053	69,734	363,886	Feb 25 04:05 PM
John Minardo	Chief Legal Officer	Feb 23 '26	Sale	3.81	17,439	66,443	382,939	Feb 25 04:05 PM
Shetzline Michael	SVP, CMO, Head-Res&Drug	Feb 23 '26	Sale	3.81	15,570	59,322	538,437	Feb 25 04:05 PM
Gaskins Tammi L	Chief Commercial Officer	Feb 24 '26	Sale	3.66	11,239	41,135	213,738	Feb 25 04:05 PM
Gaskins Tammi L	Chief Commercial Officer	Feb 23 '26	Sale	3.81	10,287	39,193	224,977	Feb 25 04:05 PM
MCCOURT Thomas A	Chief Executive Officer	Feb 24 '26	Sale	3.66	103,526	378,905	1,489,002	Feb 25 04:05 PM
MCCOURT Thomas A	Chief Executive Officer	Feb 23 '26	Sale	3.81	94,757	361,024	1,592,528	Feb 25 04:05 PM
Martini Gregory S.	Chief Financial Officer	Feb 24 '26	Sale	3.66	11,457	41,933	160,601	Feb 25 04:05 PM
Martini Gregory S.	Chief Financial Officer	Feb 23 '26	Sale	3.81	10,487	39,955	172,058	Feb 25 04:05 PM
Silver Ronald	Principal Accounting Officer	Feb 24 '26	Sale	3.66	12,621	46,193	252,636	Feb 25 04:05 PM
Silver Ronald	Principal Accounting Officer	Feb 23 '26	Sale	3.81	11,552	44,013	265,257	Feb 25 04:05 PM
Gaskins Tammi L	Officer	Feb 23 '26	Proposed Sale	4.61	19,775	91,163		Feb 20 04:46 PM
Martini Gregory S.	Officer	Feb 23 '26	Proposed Sale	4.61	20,163	92,951		Feb 20 04:45 PM
Shetzline Michael	Officer	Feb 23 '26	Proposed Sale	4.61	29,937	138,010		Feb 20 04:44 PM
John Minardo	Officer	Feb 23 '26	Proposed Sale	4.61	33,528	154,564		Feb 20 04:42 PM
MCCOURT Thomas A	Officer	Feb 23 '26	Proposed Sale	4.61	182,185	839,873		Feb 20 04:41 PM
Silver Ronald	Principal Accounting Officer	Jan 05 '26	Sale	4.60	35,416	162,914	276,809	Jan 07 04:05 PM
RONALD SILVER	Officer	Jan 05 '26	Proposed Sale	4.27	35,416	151,226		Jan 05 04:41 PM
Gaskins Tammi L	Chief Commercial Officer	Nov 17 '25	Sale	3.32	6,016	19,973	235,264	Nov 19 04:05 PM
Gaskins Tammi L	Officer	Nov 17 '25	Proposed Sale	3.37	6,324	21,312		Nov 14 04:05 PM
Gaskins Tammi L	Chief Commercial Officer	Aug 11 '25	Sale	0.84	1,316	1,105	241,280	Aug 13 04:05 PM
John Minardo	Chief Legal Officer	Aug 11 '25	Sale	0.84	7,754	6,513	400,378	Aug 13 04:05 PM
Martini Gregory S.	Chief Financial Officer	Aug 11 '25	Sale	0.84	1,265	1,063	182,545	Aug 13 04:05 PM
Silver Ronald	Principal Accounting Officer	Aug 11 '25	Sale	0.84	2,846	2,391	276,809	Aug 13 04:05 PM
John Minardo	Officer	Aug 11 '25	Proposed Sale	0.88	8,281	7,287		Aug 08 04:10 PM
Martini Gregory S.	Officer	Aug 11 '25	Proposed Sale	0.88	1,351	1,189		Aug 08 04:09 PM
Gaskins Tammi L	Officer	Aug 11 '25	Proposed Sale	0.88	1,406	1,237		Aug 08 04:08 PM
MCCOURT Thomas A	Chief Executive Officer	May 16 '25	Sale	0.58	13,353	7,745	1,147,281	May 20 04:14 PM
Gaskins Tammi L	Chief Commercial Officer	May 16 '25	Sale	0.58	2,563	1,487	242,596	May 20 04:10 PM
MCCOURT Thomas A	Officer	May 19 '25	Proposed Sale	0.59	14,661	8,650		May 16 04:07 PM
Gaskins Tammi L	Officer	May 19 '25	Proposed Sale	0.59	2,814	1,660		May 16 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Ironwood Pharmaceuticals Inc

Upgrade your FINVIZ experience